Betamethasone Acetate Market
According to Intent Market Research, the Betamethasone Acetate Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 6.9% to touch USD 1.5 billion by 2030. The Betamethasone Acetate Market is dominated by key players such as, Bristol-Myers Squibb, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, and Amgen Inc..